Baker & Eastlack Ventures
Baker & Eastlack Ventures
  • Home
  • About
  • Portfolio
  • Investment Focus
  • News
  • Contact
February 25 2020

Kurin, Inc. receives FDA 510k clearance for its push-button needle

Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, has received 510(k) clearance (k191832) for its novel push-button needle.

“The FDA clearance of our push-button needle is another important step in the continued growth of our company,” said Bob Rogers, CEO of Kurin. “Development of our proprietary needle provides us vertical integration and also allows us to offer superior options to our customers. We are experiencing exponential growth and milestones like this one position Kurin well for our rapid expansion plans,” said Mr. Rogers.

Read the entire article here: https://www.kurin.com/kurin-inc-receives-fda-510k-clearance-for-its-push-button-needle/

 

StimGuard appoints new chief financial officer Kurin Receives Additional Patent Claims

Related Posts

Uncategorized

Micron Medical Appoints Seasoned Healthcare Executive Mark Landy as Chief Executive Officer

Uncategorized

Zerigo Now Approved as a MultiPlan Participating Provider

Uncategorized

Spinal Singularity Hires New CEO

Baker & Eastlack Ventures

Contact Us

Email: bakerandeastlack@gmail.com

© Baker & Eastlack Ventures 2023